Bayer, Reckitt among final contenders for Merck consumer health care unit
Merck & Co. Inc. is in the final stages of selling its consumer health care unit for nearly $14 billion, with Bayer AG and Reckitt Benckiser Group Plc among final contenders to clinch a deal as soon as this week, people familiar with the matter said.
Germany's Bayer and British consumer products giant Reckitt have emerged as front-runners to win the auction after each offering about $13.5 billion for the Merck consumer unit, best known for Coppertone sunscreen and Claritin allergy medicine, the sources said.
Both bidders are very keen to buy the asset, and the price tag could go higher in the final days, one person added. All the people asked not to be named because the matter is not public.
Representatives of American drugmaker Merck, as well as Bayer and Reckitt, declined to comment.
Show commenting policy
TribLive commenting policy
- Fight against Islamic State at impasse, military commanders say
- Doctor 1st Ebola virus case in New York City
- Federal officials: Dallas nurse free of Ebola
- West Virginia University expels 3 students for postgame misconduct
- Detainee to be transferred from Afghanistan to U.S. for trial
- Feds fault security of tax info gathered for health care law benefits
- White House may enhance security
- Court: IRS not targeting conservative tax-exempt groups
- Man shot from behind, Wecht’s autopsy finds
- Sen. Casey seeks to cut off benefits to ex-Nazis
- Internet providers asked not to take ‘fast lanes’